Electrical Impedance Myography Correlates with Functional Measures of Disease Progression in D2-mdx Mice and Boys with Duchenne Muscular Dystrophy

被引:4
|
作者
Chrzanowski, Stephen M. [1 ,2 ]
Nagy, Janice A. [2 ]
Pandeya, Sarbesh [2 ]
Rutkove, Seward B. [2 ]
机构
[1] Boston Childrens Hosp, Dept Neurol, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave, Boston, MA 02215 USA
关键词
Electrical impedance myography; duchenne muscular dystrophy; D2-mdx mice; biomarker; functional outcome measures; HELD ELECTRODE ARRAY; QUANTITATIVE ULTRASOUND; MUSCLE; MANAGEMENT; DIAGNOSIS; ATROPHY;
D O I
10.3233/JND-210787
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Sensitive, objective, and longitudinal outcome measures applicable to both pre-clinical and clinical interventions are needed to assess muscle health in Duchenne muscular dystrophy (DMD). Electrical impedance myography (EIM) has the potential to non-invasively measure disease progression in mice and boys with DMD. Objective: We sought to evaluate how electrical impedance values (i.e., phase, reactance, and resistance) correlate to established measures of disease in both D2-mdx and wild type (WT) mice and boys with and without DMD. Methods: Histological, functional, and EIM data collected from previous studies of WT and D2-mdx mice at 6, 13, 21 and 43 weeks of age were reanalyzed. In parallel, previously collected functional outcome measures and EIM values were reanalyzed from boys with and without DMD at four different age groups from 2 to 14 years old. Results: In mice, disease progression as detected by histological, functional, andEIMmeasures, was appreciable over this time period and grip strength best correlated to longitudinal phase and reactance impedance values. In boys, disease progression quantified through commonly utilized functional outcome measures was significant and longitudinal phase demonstrated the strongest correlation with functional outcome measures. Conclusion: Similar changes in EIM values, specifically in longitudinal reactance and phase, were found to show significant correlations to functional measures in both mice and boys. Thus, EIM demonstrates applicability in both pre-clinical and clinical settings and can be used as a safe, non-invasive, and longitudinal proxy biomarker to assess muscle health in DMD.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 50 条
  • [31] Functional outcome measures in young, steroid-naive boys with Duchenne muscular dystrophy
    Mayhew, Anna G.
    Moat, Dionne
    McDermott, Michael P.
    Eagle, Michelle
    Griggs, Robert C.
    King, Wendy M.
    James, Meredith K.
    Muni-Lofra, Robert
    Shillington, Alison
    Gregson, Sarah
    Pallant, Lindsey
    Skura, Christy
    Staudt, Loretta A.
    Eichinger, Katy
    McMurchie, Heather
    Rabb, Rosanna
    Di Marco, Marina
    Brown, Sarah
    Zanin, Riccardo
    Arnoldi, Maria Teresa
    McIntyre, Melissa
    Wilson, Amelia
    Alfano, Lindsay N.
    Lowes, Linda P.
    Blomgren, Colleen
    Milev, Evelin
    Iodice, Mario
    Pasternak, Amy
    Chiu, Angela
    Lehnert, Ilka
    Claus, Nicole
    Dieruf, Kathy A.
    Rolle, Enrica
    Nicorici, Alina
    Andres, Barbara
    Hobbiebrunken, Elke
    Roetmann, Gerda
    Kern, Victoria
    Civitello, Matthew
    Vogt, Sibylle
    Hayes, Melissa J.
    Scholtes, Cheryl
    Lacroix, Catherine
    Gunn, Tara
    Warner, Sinead
    Newman, Jennifer
    Barp, Andrea
    Kundrat, Katherine
    Kovelman, Staci
    Powers, Penny J.
    NEUROMUSCULAR DISORDERS, 2022, 32 (06) : 460 - 467
  • [32] Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse
    Boccanegra, Brigida
    Lenti, Roberta
    Mantuano, Paola
    Conte, Elena
    Tulimiero, Lisamaura
    Piercy, Richard J.
    Cappellari, Ornella
    Hildyard, John C. W.
    De Luca, Annamaria
    PLOS ONE, 2024, 19 (11):
  • [33] Humanizing Mouse Sialylation Humanizes Disease Progression in the Mdx Mouse Model for Duchenne Muscular Dystrophy
    Chandrasekharan, Kumaran
    Yoon, Jung Hae
    Xu, Ying
    Devries, Sarah
    Camboni, Marybeth
    Janssen, Paulus
    Varki, Ajit
    Martin, Paul
    GLYCOBIOLOGY, 2009, 19 (11) : 1289 - 1289
  • [34] AT-300, a calcium modulator, improves muscle force production and decreases muscle degeneration in D2-mdx model of Duchenne muscular dystrophy
    Bush, E.
    Ward, C.
    Suchyna, T.
    Sacks, F.
    Blaustein, M.
    Escolar, D.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S192 - S192
  • [35] Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy
    Gholamreza Zamani
    Sareh Hosseinpour
    Mahmoud Reza Ashrafi
    Mahmoud Mohammadi
    Reza Shervin Badv
    Ali Reza Tavasoli
    Masood Ghahvechi Akbari
    Ali Hosseini Bereshneh
    Reza Azizi Malamiri
    Morteza Heidari
    BMC Neurology, 22
  • [36] Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy
    Zamani, Gholamreza
    Hosseinpour, Sareh
    Ashrafi, Mahmoud Reza
    Mohammadi, Mahmoud
    Badv, Reza Shervin
    Tavasoli, Ali Reza
    Akbari, Masood Ghahvechi
    Bereshneh, Ali Hosseini
    Malamiri, Reza Azizi
    Heidari, Morteza
    BMC NEUROLOGY, 2022, 22 (01)
  • [37] Functional Mixed-Effects Modeling of Longitudinal Duchenne Muscular Dystrophy Electrical Impedance Myography Data Using State-Space Approach
    Kapur, Kush
    Sanchez, Benjamin
    Pacheck, Adam
    Darras, Basil
    Rutkove, Seward B.
    Selukar, Rajesh
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2019, 66 (06) : 1761 - 1768
  • [38] Dnm2 reduction combined with dystrophin re-expression ameliorates the myopathic phenotype observed in the D2-mdx model of Duchenne muscular dystrophy
    Menuet, A.
    Buono, S.
    Robe, A.
    Chhor, S.
    Eyler, L.
    Becker, J.
    Colombo, S.
    Cowling, B.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S99 - S99
  • [39] Treatment of Young Boys with Duchenne Muscular Dystrophy with the NF-κB Inhibitor Edasalonexent Showed a Slowing of Disease Progression as Assessed by MRI and Functional Measures
    Finkel, R.
    Vandenborne, K.
    Sweeney, H.
    Finanger, E.
    Tennekoon, G.
    Shieh, P.
    Willcocks, R.
    Walter, G.
    Rooney, W.
    Forbes, S.
    Triplett, W.
    Yum, S.
    Mancini, M.
    MacDougall, J.
    Donovan, J.
    ANNALS OF NEUROLOGY, 2019, 86 : S29 - S29
  • [40] Disease course in mdx:utrophin(+/-) mice: comparison of three mouse models of Duchenne muscular dystrophy
    McDonald, Abby A.
    Hebert, Sadie L.
    Kunz, Matthew D.
    Ralles, Steven J.
    McLoon, Linda K.
    PHYSIOLOGICAL REPORTS, 2015, 3 (04):